This pre conference symposium taking place on the 8th June will be analysing the Critical Importance of Open Innovation within the Pharmaceutical Industry.
With the increasing cost of bringing a drug to market alongside a decline in productivity, changes to the traditional pharmaceutical business model need to be made to increase both Innovation and ROI. Hear the thoughts of leading influential thinkers to the benefits of Open Innovation (OI) including their views on topics such IP & collaboration Issues whilst discussing the value OI can bring to Pharmaceutical R&D.
Over the day the topic areas that will be explored include:-
Business Models
IP and Collaboration Issues
Academia OI
Biopharma OI
Current OI Initiative Case Studies
Lessons learned from outside Pharma
During the discussions you will:
· Interact with your peers who are also working with Open Innovation.
· Discuss with senior executives the value of OI so you can exploit it.
· Assess a new method of working
· Bench mark your work with other companies who are already using OI to their benefit.
The symposium will be a mixture of individual presentations, panel and roundtable discussions to maximise interaction and learning from parties from academia, pharma and biotech companies. The symposium will be chaired by Thomas Senderovitz, Vice President Global Exploratory Development, UCB New Medicines.
Already confirmed to speak are:
· Thomas Senderovitz, Vice President Global Development, Gruenthal
· Philip Oliver, Associate Director for Global External R&D Europe, Eli Lilly
· Giuseppe Ciaramella, Executive Director, Head of Biotherapeutics, Sandwich, Pfizer
· Chas Bountra, Chief Scientist, University of Oxford, Structural Genomics Consortium
· Peter Luke, Senior Director Worldwide Business Development (Strategic Alliances), Pfizer
· Patrice Talaga, Director, Chemistry Outsourcing, UCB
· Jason Swedlow, Professor of Quantative Cell Biology Wellcome Trust Centre for Gene Regulation & Expression, College of Life Sciences, University of Dundee
· Rob Cooke, Director, Science Envrionment Development, GSK
The Symposium is currently at an early stage of development – Should you wish to make a presentation or be interested in putting your views across within a panel discussion then please get in touch with me @ M.Burden@oxfordglobal.co.uk to discuss your involvement.
A more detailed programme for the agenda will follow shortly.
